IQ4I Published a New Report on "Vascular and Non-Vascular Stents Global Market - Forecast to 2021"
10/16/2015

The global vascular and non-vascular market is valued at $8.3bn in 2014. This report analyzes the stent market in terms of market revenue ($mn) for all segments

Online PR News – 16-October-2015 – bangalore – The global vascular and non-vascular market is valued at $8.3 billion in 2014. This report analyzes the stent market in terms of market revenue ($ million) for all segments. The market analysis is performed by TYPES (Bare metal, Drug eluting, Bio-resorbable & other stents); APPLICATONS (Vascular stents {Coronary & Peripheral} & Non-vascular stents {Gastrointestinal, Airway, Urology, Ophthalmology & Others}); MATERIALS (Metals stents {Cobalt Chromium, Nickel-Titanium Alloy, Platinum-Chromium, Stainless Steel & Others} & Polymers stents {Durable & Bio-absorbable}); COATINGS (Coated {Inorganic, Polymer, Polymer free & Others} & Non-coated stents); REGION (North America, Europe, Asia Pacific and Rest of the World).
Stents are devices used in the body for treating weak or narrow blood vessels caused due to plaque formation. Stents helps in improvement of the blood flow and prevents the blood vessels from bursting. Increased preferences of minimally-invasive procedures, growing aging populations, increasing incidence of metabolic diseases, technological advancements in stent technologies such as bio-degradable polymer and polymer-free coated stents, bio-resorbable vascular scaffold (BVS) and improvement in healthcare infrastructure and services are driving the growth of the market.
Slashing prices of stents, less adoption and long-term efficacy of novel technologies, and side effects associated with stenting procedures such as allergic reactions, in-stent restenosis and stent thrombosis are hampering the market growth.
North America accounted for the largest share in 2014 due to the introduction of new technologies by leading players, growing awareness and increased prevalence of arterial diseases and Asia-pacific region is expected to grow at the highest CAGR during the forecast period due to government initiatives for modernization of healthcare infrastructure, and increasing focus of both international and domestic players on the stents market.
The global stents market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the stents market are Abbott laboratories (U.S.), B.Braun (Germany), Biosensors (Singapore), Boston scientific (U.S.), Cordis Corporation (U.S.), Medtronic (Ireland), Olympus (Japan), Microport (China), Terumo (Japan), Biotronik (Germany) Cook Medical (U.S) and C.R.Bard (U.S.).
Reasons for buying this report:
• Market assessment of all segments and sub segments of Stents market
• In-depth market sizing analysis of various segments and sub segments of Types, Coatings, Materials, Applications and Regional markets
• Regulatory scenario across the globe
• Reimbursement Scenario
• Supply Chain Analysis
• Upcoming Technologies
• Patent Analysis
• Market share analysis of key players